NURS 329 Quiz #2 questions and answers 2026\2027
A+ Grade
A patient has been prescribed pharmacologic doses of glucocorticoids. It is most important for the nurse
to teach the patient to do what?
A. Increase intake of dietary sodium.
B. Take antibiotics to prevent infection.
C. Never abruptly withdraw therapy.
D. Have an eye examination every year
- correct answer C. Never abruptly withdraw therapy.
Which of the following drugs has no anti-inflammatory properties and blocks transmission of pain
impulses peripherally?
A. Acetaminophen (Tylenol)
B. Aspirin (ASA)
C. Tramadol (Ultram)
D. All of the above
- correct answer A. Acetaminophen (Tylenol)
The nurse is caring for a patient with anemia related to chronic renal failure. Which agent might be used
to treat the anemia?
a. Filgrastim [Neupogen]
b. Sargramostim [Leukine]
c. Oprelvekin [Neumega]
d. Epoetin alfa [Procrit]
- correct answer d. Epoetin alfa [Procrit]
,The nurse is administering epoetin alfa [Procrit] to a patient receiving chemotherapy. Which adverse
effect is a potential risk with this drug?
a. Accelerated tumor progression
b. Hypotension
c. Easy bruising
d. Bone pain
- correct answer a. Accelerated tumor progression
The nurse is caring for a patient undergoing cancer chemotherapy who presents with rash, bone pain,
hypertension, and pedal edema. Which symptom is most likely an adverse reaction to the filgrastim
[Neupogen] the patient is receiving?
a. Rash
b. Bone pain
c. Headache
d. Swelling in feet
- correct answer b. Bone pain
The nurse is evaluating the effectiveness of the drug oprelvekin [Neumega] in a patient undergoing
cancer chemotherapy. Which finding is most indicative that this drug is having its intended effect?
a. Platelet count of 150 × 103/mm3
b. Hemoglobin level of 13.2 g/dL
c. White blood cell count of 5500/mm3
d. Total lymphocyte count of 1000/mm3
- correct answer a. Platelet count of 150 × 103/mm3
Which finding indicates a positive outcome from treatment with filgrastim [Neupogen]?
, a. Bone pain is eliminated.
b. The neutrophil count increases.
c. Cancer goes into remission.
d. The red blood cell count increases.
- correct answer b. The neutrophil count increases.
The healthcare provider prescribes hematopoietic growth factor for a patient. The nurse should notify
the healthcare provider to question the prescription for which patient condition?
a. A patient with chronic renal failure (CRF)
b. A patient with uncontrolled hypertension
c. A patient taking zidovudine for human immunodeficiency virus (HIV)
d. A patient with nonmyeloid malignancy chemotherapy-induced anemia
- correct answer b. A patient with uncontrolled hypertension
A patient with nonmyeloid cancer is receiving oprelvekin [Neumega]. Which adverse effects are most
likely associated with this drug? (Select all that apply.)
a. Hypertension
b. Accelerated tumor progression
c. Fluid retention
d. Atrial fibrillation
e. Anaphylactic reactions
- correct answer c, d, and e
The nurse should review which baseline data before starting epoetin alfa [Epogen] therapy in a patient
with chronic renal failure (CRF)? (Select all that apply.)
a. Ferritin level
b. Temperature trends
c. Blood glucose level
A+ Grade
A patient has been prescribed pharmacologic doses of glucocorticoids. It is most important for the nurse
to teach the patient to do what?
A. Increase intake of dietary sodium.
B. Take antibiotics to prevent infection.
C. Never abruptly withdraw therapy.
D. Have an eye examination every year
- correct answer C. Never abruptly withdraw therapy.
Which of the following drugs has no anti-inflammatory properties and blocks transmission of pain
impulses peripherally?
A. Acetaminophen (Tylenol)
B. Aspirin (ASA)
C. Tramadol (Ultram)
D. All of the above
- correct answer A. Acetaminophen (Tylenol)
The nurse is caring for a patient with anemia related to chronic renal failure. Which agent might be used
to treat the anemia?
a. Filgrastim [Neupogen]
b. Sargramostim [Leukine]
c. Oprelvekin [Neumega]
d. Epoetin alfa [Procrit]
- correct answer d. Epoetin alfa [Procrit]
,The nurse is administering epoetin alfa [Procrit] to a patient receiving chemotherapy. Which adverse
effect is a potential risk with this drug?
a. Accelerated tumor progression
b. Hypotension
c. Easy bruising
d. Bone pain
- correct answer a. Accelerated tumor progression
The nurse is caring for a patient undergoing cancer chemotherapy who presents with rash, bone pain,
hypertension, and pedal edema. Which symptom is most likely an adverse reaction to the filgrastim
[Neupogen] the patient is receiving?
a. Rash
b. Bone pain
c. Headache
d. Swelling in feet
- correct answer b. Bone pain
The nurse is evaluating the effectiveness of the drug oprelvekin [Neumega] in a patient undergoing
cancer chemotherapy. Which finding is most indicative that this drug is having its intended effect?
a. Platelet count of 150 × 103/mm3
b. Hemoglobin level of 13.2 g/dL
c. White blood cell count of 5500/mm3
d. Total lymphocyte count of 1000/mm3
- correct answer a. Platelet count of 150 × 103/mm3
Which finding indicates a positive outcome from treatment with filgrastim [Neupogen]?
, a. Bone pain is eliminated.
b. The neutrophil count increases.
c. Cancer goes into remission.
d. The red blood cell count increases.
- correct answer b. The neutrophil count increases.
The healthcare provider prescribes hematopoietic growth factor for a patient. The nurse should notify
the healthcare provider to question the prescription for which patient condition?
a. A patient with chronic renal failure (CRF)
b. A patient with uncontrolled hypertension
c. A patient taking zidovudine for human immunodeficiency virus (HIV)
d. A patient with nonmyeloid malignancy chemotherapy-induced anemia
- correct answer b. A patient with uncontrolled hypertension
A patient with nonmyeloid cancer is receiving oprelvekin [Neumega]. Which adverse effects are most
likely associated with this drug? (Select all that apply.)
a. Hypertension
b. Accelerated tumor progression
c. Fluid retention
d. Atrial fibrillation
e. Anaphylactic reactions
- correct answer c, d, and e
The nurse should review which baseline data before starting epoetin alfa [Epogen] therapy in a patient
with chronic renal failure (CRF)? (Select all that apply.)
a. Ferritin level
b. Temperature trends
c. Blood glucose level
